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Introduction {#sec1}
============

Epithelial polarization and organization of a central lumen is a defining aspect of nervous system formation. During early vertebrate neurulation the neural plate is formed, which subsequently undergoes folding to form the neural tube. At early stages, before and shortly after closure of the neural tube, the neuroepithelium consists of self-renewing, tight-junction-forming neural progenitor cells (NPCs) whose apical domains all face toward a central lumen that contains the cerebrospinal fluid. At later stages, junctional complexes are remodeled; cells lose tight junctions and their polarized morphology, and at the same time the onset of neuronal differentiation begins ([@bib1]).

The capability of tight-junction-containing NPCs to organize into polarized, lumen-containing structures is also evident during neural organoid formation ([@bib8], [@bib22]) and in two-dimensional cultures of mouse embryonic day 8 (E8) primary neural plate cell explants that spontaneously self-cluster to form two-dimensional mini-lumina termed "neural rosettes" ([@bib9]). Neural rosettes consist of small cellular units in which the NPCs all orient their apical domain to a common lumen-like center. Due to their self-organizing capacity, neural rosettes can be regarded as *in vitro*, two-dimensional versions of the neural tube. Similar to the gradual loss of neural stem cell identity in the developing neural tube, the ability of neuroepithelial cell explants derived from E8 mouse embryos to organize in rosettes is also restricted to a short window of early neural development prior to a loss of polarization. It has been difficult to maintain rosettes in culture as they tend to spontaneously progress toward more differentiated, less polarized phenotypes ([@bib9]).

An alternative source of rosette-forming, tight-junction-containing neuroepithelium has been mouse and human embryonic stem cells (hESCs) early after neural lineage induction. The early rosette-forming neuroepithelial state is considered an important state for stem cell differentiation, as it represents the early neural plate or neural tube stage at which cells have committed to the neural lineage but are still susceptible to instructive cues that pattern the CNS along the anterior/posterior and dorsal/ventral axes ([@bib2], [@bib9], [@bib18]). In hESCs, dual inhibition of SMAD signaling by noggin/dorsomorphin and SB431542 efficiently directs cells along the neural lineage and results in rosette formation ([@bib3], [@bib36]). However, upon passaging, cells successively form smaller rosettes in which cell polarization and tight junctions become reduced over time until the neuroepithelial cell state is lost. [@bib9] reported that addition of SHH and the Notch signaling agonists Delta and Jagged1 during plating of rosette-forming NPCs could prolong the rosette-forming state for approximately four passages by presumably promoting self-renewing cell divisions.

Few studies have identified signaling factors that control growth and expansion of the luminal neural tube-like area independent of cell proliferation, and beyond the factors mentioned above there are no known factors that specifically sustain a large rosette-forming neuroepithelial state. Identification of factors that can sustain/promote neuroepithelial lumen formation independently of or parallel to self-renewing divisions should have a profound effect on propagating the neural rosette-forming state and might forestall the timely differentiation to later-stage neural progenitors/committed cells. Interestingly, the sustained self-renewal of early neuroepithelial cells is a characteristic feature of spinal cord regeneration in the axolotl, where spinal cord lesions induce cells to enter the neuroepithelial state. This state is sustained and self-renews for at least 2 weeks to yield an outgrowth of the severed spinal cord tube ([@bib25], [@bib26]).

Given the importance of the tight-junction-containing early neuroepithelial state during neural tube formation/regeneration in the axolotl, we sought to identify a molecular factor that promotes expansion of the apical lumen in neuroepithelial rosette cells. Here we have identified lysophosphatidic acid (LPA) as a molecule that can cause an expansion of the apical domain of axolotl and human NPCs and a growth of the rosette luminal area independent of cell proliferation. Continuous treatment of hESC-derived NPCs with LPA yields the propagation of the rosette-forming state for at least 52 passages. Correspondingly, we see a suppression of neuronal differentiation and sustenance of the SOX2^+^, proliferative state. LPA acts through Rho and serum response factor (SRF) to promote upregulation of tight-junction actin-related- and apically associated proteins.

Results {#sec2}
=======

Addition of Serum or LPA to Axolotl and Human NPCs Induces Rosette Enlargement {#sec2.1}
------------------------------------------------------------------------------

Axolotl spinal cord regeneration is a unique system in which an injury-initiated wound response induces the self-renewal and expansion of NPCs that grow a lumen-containing neural tube, which can recapitulate neural patterning ([@bib25], [@bib31]). A key extracellular mediator of the injury response is serum. In studies of limb regeneration two serum components, BMP4/7 and PDGF, were shown to induce proliferation ([@bib30]) and cell migration ([@bib4]). We therefore asked whether serum and any of its major components could induce an expansion of neuroepithelial rosette formation in cultured axolotl spinal cord cells. While the two-dimensional neural rosettes do not represent closed lumina, they still represent neural tube-like structures that recapitulate many features of a true lumen and thus can be used to identify factors affecting lumen organization. We exposed axolotl spinal cord-derived SOX2^+^ NPCs to a 3-day pulse of serum. Strikingly we observed the organization of the cells into larger rosette structures over time ([Figure 1](#fig1){ref-type="fig"}A, upper left and middle panels). To identify the serum component responsible for this effect, we assayed LPA, which is a major signaling phospholipid in serum. When we exposed cells to concentrations of LPA in a similar range compared with those measured in serum ([@bib35]), we recapitulated the larger rosette phenotype similar to the phenotype observed with serum treatment ([Figure 1](#fig1){ref-type="fig"}A, upper right panel). We concluded that LPA is a serum-borne signaling molecule that can induce rosette enlargement in axolotl spinal cord NPCs. We next asked whether the action of LPA represents a conserved signaling pathway that can regulate rosette lumen size in other vertebrate neuroepithelia. We therefore tested whether serum and LPA induced an increase in rosette size in hESC-derived NPCs. We implemented a modified version of a three-dimensional dual SMAD signaling inhibition neural differentiation protocol, which efficiently converted hESCs into small rosette-forming SOX1^+^ NPCs ([@bib14]) ([Figures 1](#fig1){ref-type="fig"}A \[lower left panel\] and [S1](#mmc1){ref-type="supplementary-material"}). Upon incubation with serum or LPA, the human NPCs reorganized to form larger rosettes within 18--24 hr, indicating that the signaling pathway leading to larger rosette structures is conserved between axolotl and human NPCs ([Figure 1](#fig1){ref-type="fig"}A, lower middle and right panels).Figure 1Serum and LPA Induce Large Rosette Formation in Cultured Axolotl and Human NPCs(A) Immunostaining of axolotl- and hESC-derived NPCs for SOX2 (upper panels), and SOX1 and ZO-1 (lower panels) shows induction of large rosette formation in the presence of serum or LPA. F-actin in axolotl NPCs was stained with Alexa Fluor 647 phalloidin. Scale bars, 200 μm (upper panels) and 100 μm (lower panels).(B and C) Immunostaining of hESC-derived NPCs for Nestin, Vimentin, SOX1, SOX2, N-cadherin, aPKC and ZO-1. F-actin was labeled with Alexa Fluor 488 phalloidin. y-x images represent top view and z-x images side view. Scale bars, 50 μm (B) and 10 μm (C).(D) Immunostaining of NPCs that have formed enlarged rosettes after 18 hr of exposure to different LPA concentrations (0--22.5 μM) for SOX1 and ZO-1. Scale bar, 100 μm.(E and F) Quantification of the frequencies of the apical rosette lumen size areas in μm^2^ and the number of SOX1^+^ cells per rosette at different LPA levels. Red dots indicate individual apical rosette lumen sizes (E) and number of SOX1^+^ cells participating in rosette formation (F).(G) Mean number of rosettes ± SEM per analyzed image. Statistical analysis was performed using an ANOVA test followed by Tukey's a posteriori test. ^∗^p \< 0.05, n *=* 3 independent experiments.All nuclei were labeled with Hoechst 33342. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Human NPCs Express Early NSC Markers and Exhibit Apical to Basal Polarity {#sec2.2}
-------------------------------------------------------------------------

Rosette NPCs are considered to represent a neural stem cell (NSC) type whose lumen-organizing capacity and neuroepithelial marker expression strongly resembles early neuroepithelium at the neural plate stage ([@bib9], [@bib18]). We characterized the human neural rosettes with respect to their neuroepithelial marker expression. Both control small rosette and LPA-induced large rosette NPCs expressed the intermediate filament proteins Nestin and Vimentin and the neuroectodermal transcription factors SOX1 and SOX2. Consistent with their ability to organize a lumen-like structure, the NPCs in both conditions expressed the apically localized proteins ZO-1, N-cadherin, atypical protein kinase C (aPKC), CD133 and showed enriched localization of F-actin at their apical side ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [S2](#mmc1){ref-type="supplementary-material"}). While control and LPA-treated NPCs expressed similar neuroepithelial and polarity markers, we observed striking differences in the spatial organization of the cells. In control rosettes the lumen exhibited a strongly constricted morphology with clustering of the ZO-1 signal into a defined point ([Figure 1](#fig1){ref-type="fig"}C, lower and middle left panels). In contrast, in the presence of LPA the luminal surface became much larger and cells adopted an unconstricted morphology in which the individual cell-cell junctions were easily recognizable by staining for ZO-1 ([Figure 1](#fig1){ref-type="fig"}C, lower and middle right panels).

LPA Increases Lumen Size in a Concentration-Dependent Manner in Human Neural Rosettes {#sec2.3}
-------------------------------------------------------------------------------------

We further assessed whether the LPA-induced rosette size increase could be regulated by incubating the cells with different LPA concentrations. Exposure of NPCs to different LPA doses over a period of 18 hr resulted in the formation of larger rosettes with larger luminal surfaces in a concentration-dependent manner ([Figure 1](#fig1){ref-type="fig"}D). We defined the lumen surface area as the entire ZO-1-positive area completely enclosed by SOX1^+^ nuclei. Quantification revealed that distributions of apical rosette lumen area are shifted toward larger values. In particular, lower quartiles, upper quartiles, and interquartile ranges monotonically increase from 59.4, 101.6, and 42.2 μm^2^ to 64.1, 760.9, and 696.9 μm^2^, respectively, in response to 22.5 μM LPA ([Figure 1](#fig1){ref-type="fig"}E). We next quantified the number of SOX1^+^ cells per rosette. Analogously with rosette lumen area, lower quartiles, upper quartiles, and interquartile ranges monotonically increase from 24, 40, and 16 to 50, 134, and 84 cells, respectively ([Figure 1](#fig1){ref-type="fig"}F). Concomitant with the increase in rosette size, the total number of rosettes per image decreased from a mean of 508 ± 39 to 106 ± 15 rosettes ([Figure 1](#fig1){ref-type="fig"}G).

Human NPCs Can Form Large Rosettes in the Absence of Cell Proliferation {#sec2.4}
-----------------------------------------------------------------------

We next investigated whether the LPA-mediated increase in lumen size was a consequence of increased proliferation. Depending on the cell origin and the culturing conditions, hESC-derived and induced pluripotent stem cell (iPSC)-derived NPCs have been reported to either increase or decrease their proliferation in response to LPA ([@bib10], [@bib13], [@bib24]). We measured proliferation in response to LPA concentrations ranging from 0.5 μM to 2.5 μM by quantifying the percentage of 5-ethynyl-2′-deoxyuridine (EdU)^+^/SOX1^+^ cells, which revealed a 66% increase in the proliferative activity of NPCs that were exposed to 0.5 μM LPA compared with the control. Concentrations higher than 0.5 μM did not further significantly increase proliferation ([Figures 2](#fig2){ref-type="fig"}A and 2B).Figure 2Cell Proliferation Is Not Required for Large Rosette Formation in Human NPCs(A) EdU incorporation in NPCs in response to LPA. EdU signal (green) and immunofluorescence for SOX1 (red) show robust incorporation of EdU. Scale bar, 100 μm.(B) Quantification of EdU^+^/SOX1^+^ cells. Data represent mean ± SEM, ANOVA test followed by Tukey's a posteriori test. ^∗^p \< 0.05, n = 3 independent experiments.(C) Scheme depicting the experimental setup of the cell proliferation block experiment shown in (D) and (E).(D) NPCs were cultured for 12 hr in normal culturing medium (−) or in medium supplemented with 0.5 μM hydroxyurea (HU) (+). EdU signal (green) and immunofluorescence for SOX1 (red) and ZO-1 (white) show reduced EdU incorporation after HU treatment. Scale bar, 100 μm.(E) Rosette formation in the absence of proliferation. NPCs were cultured in normal culturing medium (left panels), medium supplemented with 22.5 μM LPA (middle panels), or medium supplemented with 22.5 μM LPA and 0.5 μM HU (right panels). EdU signal (green) and immunofluorescence for SOX1 (red) and ZO-1 (white). Scale bar, 100 μm.(F) Quantification of mean apical rosette lumen surface area. ANOVA test followed by Tukey's a posteriori test. Data represent mean of medians ± SEM. ^∗^p \< 0.05, n = 3 independent experiments.Prior to fixation, NPCs were incubated for 45 min with EdU (30 μM). Nuclei were labeled with Hoechst 33342 (blue). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

To test whether cells could form larger rosettes in the absence of proliferation, we blocked proliferation with the S-phase inhibitor hydroxyurea (HU). NPCs were pretreated for 12 hr with HU prior to LPA exposure ([Figures 2](#fig2){ref-type="fig"}C and 2D). After HU pretreatment, none of the cells showed EdU incorporation and LPA was added to the NPCs. Non-proliferative NPCs exposed to LPA still significantly increased their apical rosette lumen area from a mean size of 57 ± 1 μm^2^ to 131 ± 7 μm^2^. Control cells that were still proliferative responded to LPA with even larger rosette formation (206 ± 20 μm^2^) ([Figures 2](#fig2){ref-type="fig"}E and 2F). NPCs undergo interkinetic nuclear migration. During M phase the nuclei localize toward the apical site whereas during S phase they are located more basally. [@bib15] reported that nuclei of LPA-exposed ventricular zone (VZ) NPCs that were cultured in mouse E14 cerebral cortices showed displacement toward more basal regions during M phase. However, in our case immunostaining of NPCs for the mitotic marker pH3 and quantification of the distance from the apical lumen site toward the center of the surrounding pH^+^ nuclei did not significantly change the position of M-phase nuclei between both conditions ([Figure S3](#mmc1){ref-type="supplementary-material"}).

LPA Induces Apical Domain Enlargement of Human NPCs {#sec2.5}
---------------------------------------------------

To understand the changes in epithelial organization that lead to large rosette formation of NPCs, we examined rosette organization at different times after exposure of cells to 15 μM LPA. Prior to LPA exposure the NPCs were organized in small rosettes. ZO-1 could be detected at the constricted apical cell sides, which enclosed a small lumen ([Figures 3](#fig3){ref-type="fig"}A and 3B, 0 hr). Two hours after LPA administration the apical domains had slightly expanded in width ([Figures 3](#fig3){ref-type="fig"}A, 3B, and [2](#fig2){ref-type="fig"}H). After 10 hr, the NPCs had organized in a large and connected neuroepithelial-like cell layer in which the apical domains had adopted a much broader and unconstricted morphology ([Figures 3](#fig3){ref-type="fig"}A and 3B, 10 hr). After 18 hr of exposure to LPA, the apical domain areas started to shrink and appeared more constricted. At this point, the entire morphology rather resembled a cone-shaped large rosette structure than a large, connected, and flat neuroepithelium ([Figures 3](#fig3){ref-type="fig"}A and 3B, 18 hr). At 24 hr after LPA addition, the cells had completely reverted to the constricted small rosette state ([Figures 3](#fig3){ref-type="fig"}A and 3B, 24 hr). The observations indicate that LPA dynamically regulates the epithelial organization of NPCs within 24 hr. The fact that the neuroepithelial-like morphology of the NPCs, which was observed 10 hr after LPA administration, reverted over time to smaller rosettes, suggested that LPA may not be stably maintained in the culture media over time. To investigate whether the LPA activity (15 μM) is reduced within 10 hr to a level insufficient to induce a neuroepithelial-like phenotype in NPCs *de novo*, we exposed NPCs for 10 hr to 15 μM LPA and then transferred this medium to a new culture of NPCs that had not been previously exposed to LPA. The first NPC culture revealed a strong increase in the neuroepithelial-like morphology, with a mean apical area of 16 ± 2 μm^2^ per cell in LPA-treated NPCs compared with a mean apical area of 5.3 ± 0.4 μm^2^ in control NPCs ([Figures 3](#fig3){ref-type="fig"}C \[upper panels\] and [3](#fig3){ref-type="fig"}D). In contrast, the secondary NPCs that had been treated with medium from the first NPCs did not form larger rosettes in response to the media and only exhibited a mean apical area of 4.9 ± 0.7 μm^2^ ([Figures 3](#fig3){ref-type="fig"}C \[middle panels\] and [3](#fig3){ref-type="fig"}D). LPA-containing medium that had been exposed for 10 hr to NPCs and that had been supplemented with new LPA significantly induced a larger neuroepithelial-like phenotype with a mean apical area of 12.4 ± 0.7 μm^2^ per cell ([Figures 3](#fig3){ref-type="fig"}C \[lower panels\] and [3](#fig3){ref-type="fig"}D). The data show that LPA promotes the organization of NPCs into a large neuroepithelial-like cell layer as long as its activity within the medium is high and does not fall below a certain threshold ([Figure 3](#fig3){ref-type="fig"}B, dashed line). These data also show that LPA activity (15 μM) in the culture medium is reduced over a period of 10 hr to a level insufficient to induce rosette enlargement.Figure 3LPA Dynamically Regulates the Epithelial Organization and Increases Apical Domain Size of Human NPCs(A) Immunostaining of NPCs that were fixed at different time points after LPA administration for SOX1 and ZO-1. y-x images represent top view and z-x images side view. Scale bars, 10 μm.(B) Scheme depicting the changes in the epithelial organization of the NPCs over a period of 24 hr. Triangle (left side) indicates decreasing LPA activity. Dashed line indicates the critical LPA activity inside the medium required to maintain the NPCs in a large apical domain-neuroepithelial-like state. Immunostaining shows NPCs that have adopted a large neuroepithelial-like morphology after LPA treatment. Scale bar, 50 μm.(C) Upper panels: NPCs incubated with 0.5 mL of medium (left) or medium supplemented with 15 μM LPA (right). Middle panels: NPCs exposed for 10 hr to medium in which NPCs had already been cultivated for 10 hr and that was either without LPA (left) or supplemented with LPA (right). Lower panels: NPCs exposed to culture medium for 10 hr in which NPCs had already been cultivated for 10 hr and that was supplemented with new LPA. Immunostaining of NPCs for SOX1 (red) and ZO-1 (white). Scale bar, 50 μm.(D) Quantification of the mean apical area per cell in μm^2^. Data represent mean of medians ± SEM. Statistical significance was analyzed using an ANOVA test followed by Tukey's a posteriori test. ^∗^p \< 0.05, n = 3 independent experiments.(E and F) Immunostaining of NPCs for SOX1 and ZO-1 showing that NPCs exhibit different apical domain sizes in response to different LPA concentrations. (E) y-x images represent top view and z-x images side view. Scale bars, 10 μm (E) and 100 μm (F).(G) Quantification of cellular apical domain size in μm^2^. ANOVA test followed by Tukey's a posteriori test. Data represent mean of medians ± SEM. ^∗^p \< 0.05, n = 3 independent experiments.Nuclei were stained with Hoechst 33342. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

LPA Increases Apical Domain Size of Human NPCs in a Concentration-Dependent Fashion {#sec2.6}
-----------------------------------------------------------------------------------

The previous findings prompted us to investigate whether NPC apical domain size has a dose-dependent relation to the LPA concentration to which the cells are exposed. We employed a protocol whereby we exposed NPCs to stable LPA concentrations ranging from 0.3 to 20 μM for 36 hr to allow enough time for the cells to respond to LPA (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Immunofluorescence of the cells showed that the size of the apical domains, quantified as the areas of low ZO-1 signal intensity in between the cell-cell borders, concomitantly increased with increasing LPA concentrations. As a consequence of the apical expansion, small rosettes opened up their constricted morphology, and NPCs of adjacent rosettes started to connect their apical domains and fused into a larger connected epithelial cell layer ([Figure 3](#fig3){ref-type="fig"}E). Quantification revealed a significant increase in the average apical domain size per cell with increasing LPA concentrations ([Figures 3](#fig3){ref-type="fig"}F and 3G). Analysis of the dependency of apical domain size on the LPA concentrations was performed by a two-state model (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). From the results we concluded that a primary effect of LPA on the NPCs is the increase in apical domain area, where 50% of the maximal area can be achieved at 0.76 μM LPA, a concentration in the range of physiological LPA concentrations present in serum. Taken together, our results indicate that the single application of LPA leads to an early expansion of apical domains and the fusion of small rosettes into a connected cell layer. As LPA is depleted from the media and apical domains start to shrink, cells segregate into rosettes that shrink in lumen area over time. The duration of the flat neuroepithelial state and the onset of the reversion back to the large and then small rosette state can be shortened or extended by simply incubating the cells with lower or higher LPA concentrations, as demonstrated in [Figure S4](#mmc1){ref-type="supplementary-material"}.

Apical Domain Widening of Human NPCs in Response to LPA Is Transcription Dependent {#sec2.7}
----------------------------------------------------------------------------------

Apical expansion and the arrangement of epithelial cells into a large and connected cell layer would be expected to result from increased lipid incorporation into the plasma membrane, growth and stabilization of the underlying actin cortex, and remodeling of cell junctions ([Figure 4](#fig4){ref-type="fig"}A) ([@bib20], [@bib33]). To understand the molecular changes associated with apical domain widening of NPCs, we performed a microarray analysis whereby we compared the gene expression of small rosette NPCs versus LPA-treated large rosette NPCs at 2 hr, 10 hr, and 24 hr after initial exposure to LPA. Examination of all genes that showed an upregulation of at least 2-fold in one of the three time points revealed that most upregulation occurs at 10 hr and reverts to normal gene expression levels at 24 hr, probably due to decreasing LPA activity within the medium ([Figure 4](#fig4){ref-type="fig"}B). We wondered whether the strong induction of gene expression in the first 10 hr was crucial for apical domain widening, so we exposed NPCs to LPA and actinomycin D (ACTIND), a small molecule commonly used to block RNA synthesis. NPCs treated with LPA and ACTIND maintained a small rosette morphology that was not significantly different from control NPCs or control NPCs treated with ACTIND ([Figures 4](#fig4){ref-type="fig"}C and 4D).Figure 4LPA Upregulates Genes Involved in Cell Junction, Actin Cytoskeleton, and Plasma Membrane Organization in Human NPCs(A) Scheme illustrating potential important cellular processes involved in apical expansion of epithelial cells. Immunostaining depicts the small rosette state (left) and the large apical domain morphology of NPCs (right). Scale bar, 10 μm.(B) Microarray analysis of control NPCs versus LPA-treated NPCs at 2 hr, 10 hr, and 24 hr after initial LPA administration. Graph depicts expression levels of all genes that show at least an upregulation of more than 2-fold in at least one of the three time points (log~2~ scale).(C) Immunostaining of NPCs for ZO-1 and SOX2 that were cultured without LPA, with LPA, or in the presence of LPA and actinomycin D (Sigma-Aldrich, cat. no. A9415). Scale bar, 50 μm.(D) Quantification of the mean apical area per cell in μm^2^.(E−J) Functional annotation clustering of all genes upregulated more than 2-fold at 10 hr after LPA administration. The six top GO clusters exhibiting the lowest p value and highest enrichment of upregulated genes from the microarray are depicted. Clustering was performed using DAVID software. Cluster 1 = cell junction formation (E), Cluster 2 = plasma membrane (F), Cluster 3 = actin filament assembly (G), Cluster 4 = membrane-vesicle interactions (H), Cluster 5 = membrane movement and cell migration (I), Cluster 6 = plasma membrane-receptor interactions (J).(K--M) Tables showing strongly upregulated genes (\>2-fold) in response to LPA, which are associated with cell junction (K), plasma membrane (L), and actin cytoskeleton (M) organization.(N) Immunostaining of NPCs for ZO-1 and SRF showing the upregulation of SRF in response to LPA. Scale bar, 100 μm.(O) Immunostaining of NPCs for SOX1 and ZO-1 showing the involvement of ROCK and SRF in apical expansion of NPCs. Y-27632, ROCK inhibitor (Tocris, cat. no. 1254); CCG-1423, inhibitor of SRF-associated gene transcription (Sigma-Aldrich, cat. No. SML0987). Scale bar, 50 μm.(P) Quantification of the apical area per cell in μm^2^.Statistical significance in (D) and (P) was analyzed using an ANOVA test followed by Tukey's a posteriori test. ^∗^p \< 0.05, n = 3 independent experiments. Data represent mean of medians ± SEM. All nuclei were stained with Hoechst 33342. See also [Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B.

LPA Upregulates Genes Involved in Apical Membrane, Cell Cortex, and Tight-Junction Function in Human NPCs {#sec2.8}
---------------------------------------------------------------------------------------------------------

We used DAVID Bioinformatics software to identify cellular component gene ontology terms (GO_CC terms) enriched with genes that were up- or downregulated more than 2-fold in the microarray, respectively. We then performed a functional annotation clustering of the GO terms. Ordering of clusters according to their overall p value revealed that the top clusters were highly enriched in genes related to cell junction formation (cluster 1), plasma membrane (cluster 2), actin filament assembly (cluster 3), membrane-vesicle interactions (cluster 4), membrane movement and cell migration (cluster 5), and plasma membrane-receptor interactions (cluster 6) ([Figures 4](#fig4){ref-type="fig"}E--4J). Among the upregulated genes that were enriched in the six top GO clusters we found many genes related to the functions required to generate apical membrane, including actin-filament assembly-, cell junction-, plasma membrane-, and vesicle-associated genes. RNA expression levels of genes encoding for tight-junction-associated proteins of the claudin family (CLDN1, 4, 6, 23) were strongly upregulated ([@bib11]) ([Figure 4](#fig4){ref-type="fig"}K). Furthermore, RNA expression levels of genes that are translated into caveolins 1--3 (CAV1--3), which are involved in trafficking cholesterol-rich membranes that are enriched in the apical and basolateral surface, were highly induced, as well as the expression of other genes involved in apical vesicle trafficking and fusion, such as syntaxin 3 (*STX3*) and annexin A2 (*ANXA2*) ([@bib21], [@bib28], [@bib29]) ([Figure 4](#fig4){ref-type="fig"}L). The apical surface is also characterized by a strong accumulation of cortical actin and correspondingly, a strong upregulation of actin (*ACTA1*) and actin-organizing and -stabilizing genes, such as profilin 1 (*PFN1*), actinin alpha 1 (*ACTN1*), cortactin (*NF2*), ezrin (*EZR*), and spectrin β5 (*SPTBN5*) could be detected ([@bib19], [@bib27]) ([Figure 4](#fig4){ref-type="fig"}M). GO analysis of genes that were downregulated by LPA (\>2-fold) mainly resulted in GO clusters related to projections, axons, synapses, and calcium channels of neurons, indicating a bias in affected cellular components between the up- and downregulated genes ([Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}).

Rho/SRF Signaling Is Involved in the Formation of a Larger Neuroepithelial-like Morphology of Human NPCs {#sec2.9}
--------------------------------------------------------------------------------------------------------

LPA has been shown to exert many of its various cytoskeletal effects by activation of the Rho signaling pathway and the downstream transcription factor SRF, which are major regulators of actin dynamics ([@bib13], [@bib23]). We next investigated whether Rho/SRF signaling controls apical expansion and the adoption of a larger neuroepithelial-like morphology in NPCs. Immunostaining for SRF revealed a much stronger signal in LPA-treated NPCs than in control NPCs, indicating that SRF is upregulated in the presence of LPA ([Figure 4](#fig4){ref-type="fig"}N). We next tested CCG-1423, an inhibitor of SRF-driven gene expression, and Y-27632, an inhibitor of the Rho downstream kinase ROCK, on NPCs exposed to LPA. Application of both inhibitors in addition to LPA resulted in a strongly disrupted ZO-1 expression pattern compared with NPCs that were treated with LPA alone ([Figure 4](#fig4){ref-type="fig"}O). Quantification of the apical area confirmed a significant decrease per cell from 13. ± 0.5 μm^2^ in the LPA-treated NPCs toward 9 ± 1 μm^2^, 6.8 ± 0.3 μm^2^, and 4.2 ± 0.4 μm^2^ apical area in NPCs that were additionally incubated with CCG-1423, with Y-27632, or without LPA (control), respectively ([Figure 4](#fig4){ref-type="fig"}P). LPA also activates Ca^2+^-dependent signaling pathways in NPCs of the developing brain that influence many cellular processes ([@bib7]). To test the importance of calcium signaling in apical expansion, we applied the inhibitors edelfosine (blockage of phospholipase C), 2-APB (blockage of inositol triphosphate receptors), BAPTA-AM (depletion of intracellular Ca^2+^ levels), and EGTA (depletion of extracellular Ca^2+^ levels) to NPCs in the presence of LPA. The quantification of the apical area showed that exposure to 2-APB and edelfosine resulted in significantly decreased apical areas within the 5 hr of incubation time, where no toxic effects of the inhibitors were observed at the concentrations we employed ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B).

Maintenance of Apical Domain-Forming Capacity in Human NPCs over 52 Passages {#sec2.10}
----------------------------------------------------------------------------

We next investigated whether NPCs maintained their inducibility by LPA at different passage numbers. Under normal culture conditions, NPCs at RP1 or RP2 formed very large rosettes in response to LPA. However, at RP3 the ability of the cells to adopt a large rosette morphology decreased and at RP4 the cells did no longer formed large rosettes in response to a 1-day pulse-treatment of LPA ([Figure 5](#fig5){ref-type="fig"}A). Based on these results, we tested whether a continuous exposure of NPCs to LPA could maintain the competence to form large rosettes. We cultured NPCs from RP1 with a continuous exposure to 1--2 μM LPA (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Continuous exposure to this level of LPA yielded SOX2^+^ cultures with strongly expanded cellular apical domains and a large rosette morphology. The maintenance of apical domain expansion was preserved over 52 passages ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}C).Figure 5Constant LPA Exposure Maintains the Large Rosette Formation Capacity of Human NPCs(A) Immunostaining of untreated or LPA-treated NPCs at different passaging numbers for SOX1 and ZO-1. Contrast for ZO-1 signal is enhanced in upper left image. Scale bar, 100 μm.(B) NPCs that have constantly been cultured without or with LPA for 26 passages show different rosette sizes. Immunofluorescence of NPCs for SOX1 (red) and ZO-1 (white). Scale bar, 100 μm.(C) LPA prevents neuronal and glial differentiation without an increase in apoptosis. Immunostaining of NPCs for SOX1 (red), SOX2 (red), ZO-1 (white), HuC/HuD (white), GFAP (white), and CASP3 (green). Scale bars, 50 μm.(D) Quantification of the percentage of HuC^+^/HuD^+^ cells.(E) Quantification of HuC^+^/HuD^+^/CASP3^+^ double-positive cells.(F) Quantification of the average GFAP intensity (a.u.) per cell.(G) LPA exposure does not impair differentiation potential of NPCs. Cells passaged for 14 passages in LPA were either maintained in LPA (+LPA) or deprived of LPA for 5 days (LPA removed) and assayed for neural differentiation. Immunostaining of NPCs for SOX2 (red), TUBB3 (white), HuC/HuD (white), and ZO-1 (white). Scale bar, 50 μm.(H and I) Quantification of the percentage of HuC^+^/HuD^+^ cells (H) and the mean TUBB3^+^ area per cell in μm^2^ (I).For (D), (E), (F), (H), and (I), statistical significance was analyzed using a t test. ^∗^p \< 0.05, n = 3 independent experiments. Data represent mean of medians ± SEM. Nuclei were stained with Hoechst 33342. See also [Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D.

LPA Prevents Neuronal and Glial Differentiation in Early-Stage and Long-Term LPA-Treated Human NPCs {#sec2.11}
---------------------------------------------------------------------------------------------------

We further tested whether the maintenance of a large apical domain NPC phenotype yielded reduced neuronal and glial differentiation of the NPC cultures. We exposed NPCs for 3 days to constant levels of 0.5 μM LPA (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) and investigated the neuronal differentiation rates. Compared with control small rosette NPCs, the cells supplied with LPA exhibited broad apical domains with an even ZO-1 distribution ([Figure 5](#fig5){ref-type="fig"}C, upper panels). Immunostaining for the neuronal markers TUBB3 and HuC/HuD and quantification of HuC/HuD^+^ cells revealed that 3.9% ± 0.5% of the cells from the control expressed HuC/HuD, whereas 0.9% ± 0.2% of the LPA-treated NPCs showed expression ([Figures 5](#fig5){ref-type="fig"}C \[middle panels\], [5](#fig5){ref-type="fig"}D, and [S5](#mmc1){ref-type="supplementary-material"}D). LPA has been reported to increase apoptosis in hESC-derived neurospheres ([@bib10]). To exclude the possibility that the reduced neuronal differentiation rates were a consequence of an LPA-stimulated increase in apoptosis in the developing neurons, we determined the percentage of HuC/HuD^+^ cells that co-expressed the apoptotic marker caspase-3 (CASP3). Quantification of the HuC/HuD^+^/CASP3^+^ cells did not reveal a significant difference in the apoptotic rates between control NPCs and LPA-treated NPCs ([Figures 5](#fig5){ref-type="fig"}C \[middle panels\] and [5](#fig5){ref-type="fig"}E). We next assessed whether LPA exposure also prevents the transformation of NPCs toward a radial glial phenotype. Control cells cultured for 22 passages displayed high levels of glial fibrillary acidic protein (GFAP) immunofluorescence signal while NPCs cultured for 22 passages in medium continuously supplemented with LPA (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) had a markedly reduced GFAP immunofluorescence intensity, representing a 92% decreased signal ([Figures 5](#fig5){ref-type="fig"}C \[lower panels\] and [5](#fig5){ref-type="fig"}F). Finally, we asked whether NPC cells that had been cultured long term in LPA retain their neuronal differentiation potential. LPA-treated RP14 NPC cultures were deprived of LPA for 5 days and examined for markers of neuronal differentiation. 19% ± 1% of cells expressed HuC/HuD and had mean TUBB3^+^ areas of 47 ± 5 μm^2^ per cell, values that were in the range of non-LPA-treated cells (HuC/HuD, 11% ± 1%; TUBB3^+^ area/cell, 51 ± 4 μm^2^) and higher than cells that had been continuously exposed to LPA (HuC/HuD, 3.9% ± 0.2%; TUBB3^+^ area/cell, 3 ± 1 μm^2^) ([Figures 5](#fig5){ref-type="fig"}G--5I). These results indicate that propagation of rosette-forming neuroepithelia using LPA does not compromise their differentiation potential compared with controls.

Discussion {#sec3}
==========

Rosette-forming NPCs are considered to represent a very early-stage NSC type that can differentiate into diverse neuronal and glial subtypes ([@bib2], [@bib17]). Unfortunately the rosette state could not previously be maintained for many passages. So far only few factors, such as SHH and Notch signaling agonists, have been identified that are able to maintain a rosette phenotype in cultured NPCs for up to four passages presumably by promoting self-renewing cell divisions. In addition, Koch et al. developed a protocol whereby NPCs could be passaged for \>150 passages in the presence of fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF) without losing a small rosette phenotype and neuronal differentiation potential ([@bib9], [@bib16]). Here we identify LPA as a serum factor that has a major effect on the expansion of the apical membrane of cultured axolotl and human NPCs, resulting in the formation of very large rosette structures, which in the case of human NPCs can be maintained for at least 52 passages if constantly supplied with LPA. Large rosette formation of human NPCs occurs irrespective of cell proliferation but is rather a consequence of apical domain expansion and concomitant with the opening up of existing small rosettes and their fusion into larger epithelial cell clusters. The long-term LPA-treated human NPCs are competent in undergoing neuronal and glial differentiation once LPA is withdrawn from the medium. In former publications LPA has been shown to prevent neuronal, but not glial, differentiation of hESC- and iPSC-derived plated neurospheres ([@bib6], [@bib10]). Using our protocol we show that long-term LPA exposure prevents both neuronal and glial differentiation in NPCs. The opposing results could be due to differences in the culturing protocols and the timing of LPA treatment. In the future it will be interesting to assess whether long-term LPA-cultured NPCs can also yield differently patterned neuronal subtypes.

Another very interesting phenotype is the LPA-mediated expansion of the apical domain of NPCs itself. Few molecules have been shown to regulate apical domain size in epithelial cells. Deregulation of components of the Hippo signaling pathway, such as knockdown of the scaffolding protein KIBRA or expression of the CDC42 activator DBL3, can lead to apical expansion in MDCK cells. Also, overexpression of the protein Crumbs resulted in an apical expansion of *Drosophila* embryonic epithelia ([@bib32], [@bib34], [@bib38]). In our microarray we could not detect significant changes in the expression levels of the involved Hippo signaling components or Crumbs, implying that apical expansion in NPCs might be mediated by a different mechanism. Indeed, we could identify top GO term clusters and strongly induced genes related to cell junction-, actin-, and plasma membrane-related cellular processes, which have been described as important processes during the luminogenesis of epithelial tissues ([@bib5], [@bib20]). In the future, knockout studies will need to be performed to identify the key genes that promote apical expansion.

Binding of LPA to most of its receptors activates the Rho signaling pathway and the associated downstream factors ROCK1 and SRF ([@bib13], [@bib23]). In our experiments we also observed a strong dependency of large apical domain formation on ROCK1 and SRF. A literature-based metacore analysis of all SRF target genes revealed a total of 439 binding targets, among which 105 target genes were found to be up- or downregulated (\>2-fold) in our microarray data, while most of the upregulated genes were found to be transcriptional activators ([Table S3](#mmc4){ref-type="supplementary-material"} and [Figure S5](#mmc1){ref-type="supplementary-material"}E). The fact that around 25% of all SRF target genes exhibited differential gene expression in response to LPA suggests an important role for SRF in mediating apical expansion. In addition, we do not exclude that activation of the Ca^2+^ signaling pathway by LPA plays an important role in conveying apical expansion, since blockage of phospholipase C and IP3R Ca^2+^ channels by pharmacological inhibitors could also reduce apical expansion. Both signaling pathways could act in combination to promote expansion of the apical domain.

[@bib15] observed the formation of gyri and an increased cortical thickness when they cultured E14 brain sections of the mouse telencephalon in an *in vitro* slice culture system in the presence of LPA. Growth in cortical size was attributed to a larger NPC pool and increased terminal neuronal cell divisions. However, those phenotypes could hardly explain gyri formation, and it was suggested that other LPA-initiated signaling pathways might cause the folding. In our system we can also observe the formation of a large pseudostratified rosette neuroepithelium, which also contains strongly folded regions that resemble gyri. In this regard it is tempting to speculate whether an expansion of the apical domain of the NPCs close to the VZ could increase the total apical surface of the VZ, which could lead to more apical tension or a rearrangement of cells and provide a stimulus for the folding. Hence it would be interesting to find out whether folding of mouse brain cortices in the presence of ROCK or SRF inhibitor would be impaired.

During development, many future lumen-containing epithelial tissues, such as pancreatic or kidney tissue, form rosettes as intermediate structures during lumen morphogenesis. The rosettes then fuse with each other to create larger tubular structures ([@bib12]). As LPA promotes the fusion of adjacent small rosettes into larger luminal structures in our system, it will also be tempting to test whether LPA can promote the organization of other rosette-forming epithelial tissues into larger luminal structures.

Experimental Procedures {#sec4}
=======================

Axolotl NSC Culture {#sec4.1}
-------------------

Axolotl spinal cord explants were dissociated into single cells using PBS/EDTA and plated on 12-well plates coated with gelatin at a density of 32,000 cells/cm^2^. Cells were passaged every 3 weeks and cultured in DMEM/F-12 medium supplemented with human FGF2 and B27 (Gibco). For large rosette induction, the culture medium was supplemented for 3 days with either 30% fetal bovine serum or 20--50 μM LPA 1 day after passaging with a daily medium change. After 3 days of serum or LPA treatment, cells were cultured for another 25 days in normal culturing medium to allow for large rosette formation.

hESC Culture and Neural Differentiation {#sec4.2}
---------------------------------------

For hESC culture, the hESC lines H9 and H1 were used (WA09, WA01; WiCell). hESCs were cultured as described previously ([@bib37]). Neural differentiation was performed according to a modified version of published protocols ([@bib14]). hESC clumps were cultured for 5 days in low-attachment well plates in the presence of mTeSR1 medium (STEMCELL Technologies), supplemented with 2 μM dorsomorphin (Sigma-Aldrich, cat. no. 5499) and 10 μM SB431542 (Tocris, cat. no. 1614). Under floating conditions the cell clumps formed embryoid bodies (EBs). After 5 days the EBs were transferred to well plates coated with growth factor reduced Matrigel (GFRM; Corning) and cultured in the presence of the same medium. After 7 days rosettes had formed, which were dissociated with Dulbecco's PBS (without MgCl~2~, CaCl~2~)/0.1 mM EDTA into single cells and plated at a density of 450,000 cells/cm^2^ on well plates coated with GFRM. Medium was changed to N2B27 medium ([@bib37]) supplemented with human FGF2 (20 ng/mL) and mouse EGF (10 ng/mL). NPCs were passaged every 6 days (RP = rosette passaging number, which indicates how often the cells have been passaged; see also [Figure S1](#mmc1){ref-type="supplementary-material"}). For [Figure 1](#fig1){ref-type="fig"}A (lower panels) NPCs were obtained using a three-dimensional cyst-based neural differentiation protocol published previously ([@bib37]).

Immunostaining and Microscopy {#sec4.3}
-----------------------------

NPCs were fixed in 4% paraformaldehyde in plastic- or glass-bottom 24-well plates and immunostained as described previously ([@bib37]). Cells were imaged using the confocal microscopes Zeiss LSM 700, LSM 710, LSM 780, and LSM 880 (10×, 20×, 40×, and 63× objective) and the Leica DMI 4000 B (63× objective). Confocal images are either single-stack images or z stack images where maximum-intensity projection was performed. Phase-contrast images were obtained using the Leica DM IL. Images were processed using ImageJ, Photoshop, and Illustrator software. A full list with all primary and secondary antibodies is provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistics and Image Analysis {#sec4.4}
-----------------------------

Image analysis was performed by using Cell Profiler and Fiji software. For each experimental condition tested at least three independent experiments were analyzed. From each replicate either the number of rosettes per image ([Figure 1](#fig1){ref-type="fig"}G), the distribution of apical rosette area ([Figure 1](#fig1){ref-type="fig"}E), number of SOX1^+^ cells participating in rosette formation ([Figure 1](#fig1){ref-type="fig"}F), and the cellular apical domain size ([Figure 3](#fig3){ref-type="fig"}G) were determined. Since the data were non-normally distributed, the median for each replicate was determined, upon which the mean and the SEM for each experimental condition was calculated. For all other quantifications, mean and SEM were determined. After checking the homogeneity of variances by the Brown-Forsythe test, statistical comparisons were performed by a t test or ANOVA test followed by Tukey's a posteriori test when comparing two conditions or more than two conditions, respectively.
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Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S5Table S1. Functional Annotation ClusteringThis table gives a more detailed view of the six top GO term clusters that were identified by a functional annotation clustering of all the genes that were up- or downregulated in the presence of LPA (\>2-fold) and additionally shows the individual GO terms of each clusters. The data were obtained from a microarray analysis, which is presented in Figure 4, and the functional annotation clustering was performed using DAVID software (version 6.8). The respective GO terms within all the clusters, including the EASE score, the number of genes, the overall p values, and the enrichment score are shown, and the table is related to the results of part of Figure 4.Table S2. Genes Present in Top GO ClustersThis table lists all the genes that were up- or downregulated in the presence of LPA (\>2-fold) and that were found enriched in the GO terms belonging to clusters 1--6 of the up- and downregulated genes, respectively. The table depicts the gene name, gene symbol, Entrez Gene ID, fold change, and p value of the genes and therefore provides additional information related to Figure 4.Table S3. SRF Metacore AnalysisThis table provides a list of all the known SRF target genes and indicates all the genes among those up- or downregulated by LPA at different time points after exposure of the NPCs to LPA. It also provides information about the mode of action and the function of the genes. The data shown give supplemental information to the SRF metacore analysis discussed in the main text.Document S2. Article plus Supplemental Information
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